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Appraisal Correspondence
Trial quality was transparent
We are pleased to respond to the letter written by Dr 
Redfern and Dr Briffa. First, we used the PEDro scale to 
rate the quality of included trials in our meta-analysis. The 
score of included trials in our systemic review was at least 
4, half of them were 6 or 7, and the average was 5.8 (SD 
1.2). The average PEDro score of trials of physiotherapy 
interventions published in the same years as the included 
trials (ie, 1997–2008) was 5.0 (SD 1.5) (scores downloaded 
from PEDro on 17/7/2010). Therefore we do not feel that the 
trials were of particularly low quality. We agree that readers 
should consider the quality of the included trials and we 
presented the scores in Table 2 for this purpose. We also 
agree that trial quality could have been higher and that there 
is deﬁnitely a need for high-quality large scale randomised 
trials focusing on the effect of resistance training in patients 
with chronic heart failure.
As stated in our Data Analysis, heterogeneity was examined 
ﬁrst and the meta-analysis of each outcome was conducted 
with the appropriate model. We put the major signiﬁcant 
ﬁnding in the title and conclusion but also pointed out the 
limitations. We agree with Dr Redfern and Dr Briffa that 
readers should be reminded that the beneﬁt we found of 
resistance training on six-minute walk distance was based 
on the results of two studies (as we stated in the Discussion).
We thank Dr Redfern and Dr Briffa and agree that 
some studies could improve their study design by using 
concealed group allocation and by blinding investigators 
to group allocation while measuring outcomes. However, 
the comment on the diagnosis of chronic heart failure 
was somewhat misleading. As we know, heart failure is a 
clinical syndrome characterised by signs and symptoms 
of exertional dyspnoea due to structural and/or functional 
heart diseases with a range of left ventricular ejection 
fraction (LVEF) (Libby et al 2008). Some discrepancies in 
LVEF could be possible.
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